
|Articles|December 10, 2018
Rho Announces New Business Segment
Advertisement
Rho, a full-service CRO, announced a new Regulatory Strategy and Submissions business segment which will support their continued growth in helping sponsors plan, develop, and submit marketing applications. The new segment provides an integrated approach for regulatory, clinical, nonclinical, CMC, and statistical experts to work with clients.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The AI Churn Trap in Life Sciences and How to Break It
2
ACT Brief: Execution Failures and Upstream Origins, European Data Governance Reshaping CROs, and Phase-Dependent Trial Competition
3
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
4
ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism
5




